News

For the twelfth year in a row, the magazine Challenges published its selection of “100 start-ups to invest in”. More than 700 applications have been submitted and 100 start-ups have been selected, including Aqemia.

We're proud to announce Aqemia receives France Biotech award for AI in HealthTech. This award echoes recent milestones with top pharmas in the US and Europe and Aqemia's seeding of a massive, scalable, internal drug discovery pipeline.

Aqemia has brand new offices to sustain rapid growth and expansion. At our deeptech incubator Agoranov, We grew from 2 to 20 in 18 months. Our new offices located in the nice 15th arrondissement of Paris will allow us an increase of... 100% in the next 12 months.

Aqemia was present at Viva Technology, Europe biggest start up and tech event! Thank you Sanofi for inviting us. We’re also very proud of our partnership.

Aqemia gave input and insights alongside other companies for the report. It is about nature co-design, explaining how, for the first time in history, we can use nature as an engineering and manufacturing platform at the atomic level.